DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cereblon
Cereblon
P63 Is a Cereblon Substrate Involved in Thalidomide Teratogenicity
Cereblon and Its Downstream Substrates As Molecular Targets of Immunomodulatory Drugs
Chemical Ligand Space of Cereblon Iuliia Boichenko,† Kerstin Bar,̈ Silvia Deiss, Christopher Heim, Reinhard Albrecht, Andrei N
Absence of Mutations in Cereblon (CRBN) and DNA Damage-Binding Protein 1 (DDB1) Genes and Significance for Imid Therapy
Human Cereblon Alphalisa Immunoassay Detection Kit
Delineating the Role of Cooperativity in the Design of Potent Protacs for BTK
Tbx4 Function During Hindlimb Development Reveals a Novel Mechanism to Explain the Origins of Proximal Limb Defects
Cereblon – Thalidomide Complex
Genome-Wide CRISPR Screens Reveal Genetic Mediators of Cereblon Modulator Toxicity in Primary Effusion Lymphoma
Molecular Mechanisms of Cereblon-Based Drugs
UBE2G1 Governs the Destruction of Cereblon Neomorphic Substrates
Immunomodulatory Drugs and Their Therapeutic Effect in Hematological Malignancies Through Cereblon
Multiomic Analysis of Cereblon Expression and Its Prognostic Value in Kidney Renal Clear Cell Carcinoma, Lung Adenocarcinoma, and Skin Cutaneous Melanoma
The CULT Domain of Cereblon: a Pharmacological Target and Teratogenicity Gateway
In Silico Analysis of Enantioselective Binding of Immunomodulatory Imide Drugs to Cereblon Takahiro Murai1, Norihito Kawashita1,2, Yu‑Shi Tian3 and Tatsuya Takagi1,2*
Epigenetic Regulation of Kcna3-Encoding Kv1.3 Potassium Channel by Cereblon Contributes to Regulation of CD4+ T-Cell Activation
Functional Analysis of Cereblon, an Evolutionary Conserved Substrate Receptor of the Cullin4-RING E3 Ubiquitin Ligase, in Mammal
The Cullin 4A/B-DDB1-Cereblon E3 Ubiquitin Ligase Complex Mediates the Degradation of CLC-1 Chloride Channels
Top View
Cereblon Modulator Iberdomide Induces Degradation of the Transcription Factors Ikaros and Aiolos
IKZF1/3 and CRL4CRBN E3 Ubiquitin Ligase Mutations and Resistance to Immunomodulatory Drugs in Multiple Myeloma
Mutations in CRBN and Other Cereblon Pathway Genes Are Infrequently Associated with Acquired Resistance to Immunomodulatory Drugs
Cereblon Modulators: Low Molecular Weight Inducers of Protein
Imids Induce FAM83F Degradation Via an Interaction with Ck1α to Attenuate Wnt Signalling
Investigating the Mechanism and Species- Specificity of Thalidomide Derivatives
Cereblon Attenuates DNA Damage-Induced Apoptosis by Regulating the Transcription-Independent Function Of
Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4CRBN Protein Degradation Axis
Thalidomide and Its Metabolite 5‐Hydroxythalidomide Induce Teratogenicity Via the Cereblon Neosubstrate PLZF
December 19, 2019 Thalidomide Embryopathy
CRL4-Cereblon Complex in Thalidomide Embryopathy
Thalidomide Mimics Uridine Binding to an Aromatic Cage in Cereblon
AG Polymorphism in the CRBN Gene Acts As a Biomarker of Response to Treatment with Lenalidomide in Low&Sol
An Enhanced Genetic Model of Relapsed IGH-Translocated Multiple
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of Imids in Multiple Myeloma: Better to Lose Than to Find Them
CRBN), a Primary Direct Target of Thalidomide, Using Ferrite Glycidyl Methacrylate (FG) Beads
Cereblon: a Protein Crucial to the Multiple Functions of Immunomodulatory Drugs As Well As Cell Metabolism and Disease Generation
CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of Clc-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy
Tubulin Resists Degradation by Cereblon-Recruiting Protacs
Molecular Mechanisms of the Teratogenic Effects of Thalidomide
Cereblon: Molekularny Cel Leków
Structure of the DDB1-CRBN E3 Ubiquitin Ligase in Complex with Thalidomide